Handelsbanken Fonder’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Handelsbanken Fonder’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,700	Closed	-$1.01M	–	1595
2023 Q2	$1.01M	Sell	25,700 -4,400	-15%	-$155K	0.01%	737
2023 Q1	$732K	Buy	30,100 +5,000	+20%	+$109K	﹤0.01%	816
2022 Q4	$537K	Buy	25,100 +7,900	+46%	+$169K	﹤0.01%	928
2022 Q3	$309K	Hold	17,200	–	–	﹤0.01%	1241
2022 Q2	$165K	Hold	17,200	–	–	﹤0.01%	1526
2022 Q1	$289K	Buy	17,200 +1,200	+8%	+$17.7K	﹤0.01%	1535
2021 Q4	$268K	Buy	+16,000	New	+$262K	﹤0.01%	1638

Handelsbanken Fonder's ISEE Position: Q3 2023 in Review

Handelsbanken Fonder sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 25,700 shares — an estimated $1.01M sold.

Handelsbanken Fonder first reported a position in ISEE in Q4 2021 and held it in 7 quarters. The position peaked at $1.01M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Handelsbanken Fonder reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Handelsbanken Fonder sold 25,700 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.01M.
Handelsbanken Fonder first reported a position in IVERIC bio, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Handelsbanken Fonder's IVERIC bio, Inc. Common Stock position peaked at $1.01M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Handelsbanken Fonder's 13F filing for Q3 2023, filed 19 Oct 2023.